small win: Mounjaro stopped being a problem at week 45
small win: Mounjaro stopped being a problem at week 45. This is a description of what happened to me and not a plan for anybody else. Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate. The four-week…
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.
Have you held a step for longer than the four-week minimum at any point?
Have you held a step for longer than the four-week minimum at any point?
Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.
[deleted]
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.
zepbound and mounjaro are the same compound with different labels